Medicine and Dentistry
Acute Leukemia
10%
Acute Lymphoblastic Leukemia
100%
Acute Myeloid Leukemia
10%
Adolescent
62%
Adverse Event
12%
Allogenic Bone Marrow Transplantation
10%
Anaplastic Large Cell Lymphoma
10%
Anaplastic Lymphoma Kinase
10%
Arsphenamine
20%
Autologous Hematopoietic Stem Cell Transplantation
10%
Blast Cell
13%
Bone Marrow Transplantation
11%
Cell DNA
12%
Chemotherapy Agent
10%
Chloroacetic Acid
10%
Clinical Trial
11%
Combination Chemotherapy
10%
Cytarabine
30%
Disease
17%
Drug Megadose
31%
Event Free Survival
33%
Fluorescence in Situ Hybridization
10%
Gene Rearrangement
10%
Graft Versus Host Reaction
10%
Hematopoietic Stem Cell
10%
High Risk Population
10%
Hodgkin's Lymphoma
10%
Immunophenotyping
18%
Lactate Dehydrogenase
19%
Large Cell
10%
Leukemia in Children
10%
Leukocyte
38%
Lymphoblast
12%
Lymphoblastic Lymphoma
41%
Lymphoid Leukemia
12%
Lymphoma
10%
Maintenance Therapy
12%
Methotrexate
40%
Non-Hodgkin Lymphoma
12%
Oncology
41%
Overall Survival
23%
Patient with Neuroblastoma
10%
Pediatrics Patient
16%
Pleura Effusion
10%
Ploidy
10%
Recombinant Alpha2 Interferon
10%
Teniposide
28%
Toddlers
10%
Undifferentiated Lymphoma
10%
Whole Body Radiation
10%
Pharmacology, Toxicology and Pharmaceutical Science
Acute Lymphoblastic Leukemia
97%
Adverse Event
12%
Anaplastic Large Cell Lymphoma
10%
Arsphenamine
12%
Asparaginase
12%
Chemotherapy
43%
Childhood Cancer
14%
Cyclophosphamide
9%
Cytarabine
23%
Disease
15%
Down Syndrome
10%
Etoposide
9%
Event Free Survival
21%
Intrathecal
9%
Leukemia
17%
Lymphatic Leukemia
10%
Lymphoma
10%
Malignant Neoplasm
14%
Mammalian Target of Rapamycin
10%
Medulloblastoma
10%
Mercaptopurine
10%
Methotrexate
88%
Neoplasm
8%
Neuroblastoma
17%
Nonhodgkin Lymphoma
10%
Overall Survival
9%
Pharmacodynamics
10%
Pharmacokinetic Parameter
10%
Pharmacokinetics
17%
Phase I Trials
10%
Pleura Effusion
10%
Prednisone
8%
Recombinant Alpha2 Interferon
10%
Remission
64%
Survival Rate
5%
Teniposide
48%
Tioguanine
5%
Undifferentiated Lymphoma
10%
Vincristine
13%
Keyphrases
Acute Lymphoblastic Leukemia
7%
Advanced Stage
10%
Anaplastic Large Cell Lymphoma
20%
Anaplastic Lymphoma Kinase
7%
Anaplastic Lymphoma Kinase Rearrangement
10%
Antigen 43
10%
Automatic Interaction
10%
B-lymphoblastic Leukemia
10%
Calla
6%
Cerebral Metastases
10%
Childhood Acute Lymphoblastic Leukemia
24%
Chloroacetate Esterase
10%
Chromosome Abnormalities
20%
Complete Remission
10%
Detectors-methods
10%
Event-free Survival
7%
Fluorescence in Situ Hybridization
10%
Genetic Correlation
10%
Hematopoietic Cells
10%
High Incidence
10%
Human Thymus
10%
Immunohistochemical Staining
10%
Influence Probability
10%
Intensified Therapy
10%
Intensive Chemotherapy
10%
L-asparaginase
6%
Lactic Dehydrogenase
10%
Leukemia-associated Antigen
10%
Lymphoblast
7%
Lymphoblastic Lymphoma
10%
Mammalian Target of Rapamycin Pathway
10%
Metastatic Medulloblastoma
10%
Minimal Disseminated Disease
10%
Myeloid Sarcoma
10%
Myelosuppressive Chemotherapy
10%
Newly Diagnosed
10%
Occult Infection
6%
Pathological Correlation
10%
Pediatric-type Follicular Lymphoma
12%
Philadelphia Chromosome
10%
Prognostic Value
14%
Remission Induction
6%
Secondary Chromosome
10%
Standard Risk
7%
Supratentorial Primitive Neuroectodermal Tumor
10%
Teniposide
10%
Testicular Leukemia
6%
Treatment Intensification
10%
Unsuccessful Treatment
10%
Young children
10%
